Gastroenterology
Volume 134, Issue 7 , Pages 1981-1993, June 2008

The Essential Role of Fibroblasts in Esophageal Squamous Cell Carcinoma–Induced Angiogenesis

  • Kazuhiro Noma

      Affiliations

    • The Wistar Institute, Philadelphia, Pennsylvania
  • ,
  • Keiran S.M. Smalley

      Affiliations

    • The Wistar Institute, Philadelphia, Pennsylvania
  • ,
  • Mercedes Lioni

      Affiliations

    • The Wistar Institute, Philadelphia, Pennsylvania
  • ,
  • Yoshio Naomoto

      Affiliations

    • Departments of Gastroenterological Surgery, Transplant and Surgical Oncology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
  • ,
  • Noriaki Tanaka

      Affiliations

    • Departments of Gastroenterological Surgery, Transplant and Surgical Oncology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
  • ,
  • Wafik El–Deiry

      Affiliations

    • Hematology-Oncology Division, Department of Medicine, Department of Genetics, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • ,
  • Alastair J. King

      Affiliations

    • GlaxoSmithKline, Collegeville, Pennsylvania
  • ,
  • Hiroshi Nakagawa

      Affiliations

    • Gastroenterology Division, Department of Medicine, Department of Genetics, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
  • ,
  • Meenhard Herlyn

      Affiliations

    • The Wistar Institute, Philadelphia, Pennsylvania
    • Corresponding Author InformationAddress requests for reprints to: Meenhard Herlyn, DVM, or Keiran S. M. Smalley, PhD, The Wistar Institute, 3601 Spruce Street, Philadelphia, Pennsylvania 19104.

Received 17 January 2008; accepted 19 February 2008. published online 28 February 2008.

Background & Aims: Esophageal squamous cell carcinoma (ESCC) is known to be a highly angiogenic tumor. Here, we investigated the role of the stromal fibroblasts in the ESCC-induced angiogenic response using a novel 3-dimensional model. Methods: A novel assay was developed where cocultures of ESCC and esophageal fibroblasts induced human microvascular endothelial cell (HMVEC) vascular network formation in a 3-dimensional collagen gel. Biochemical studies showed that the ESCC-induced activation of the fibroblasts was required to induce vascular network formation via a transforming growth factor (TGF)-β and vascular endothelial growth factor (VEGF)-dependent pathway. Results: Conditioned media from a panel of 4 ESCC lines transdifferentiated normal esophageal fibroblasts into myofibroblasts via TGF-β signaling. The presence of fibroblasts was essential for efficient HMVEC network formation, and the addition of ESCC cells to these cultures greatly enhanced the angiogenic process. The role of TGF-β in this process was shown by the complete inhibition of network formation following TGF-β inhibitor treatment. Finally, we showed that ESCC-derived TGF-β regulates angiogenesis through the release of VEGF from the fibroblasts and that the VEGF release was blocked following TGF-β inhibition. Conclusions: This study shows the essential role of fibroblasts in the ESCC angiogenic-induced response and suggests that the pharmacologic targeting of the TGF-β signaling axis could be of therapeutic benefit in this deadly disease.

Abbreviations used in this paper: CAF, carcinoma-associated fibroblast, DAPI, 4′,6-diamidino-2-phenylindole, DMEM, Dulbecco's modified Eagle medium, ELISA, enzyme-linked immunosorbent assay, ESCC, esophageal squamous cell carcinoma, FBS, fetal bovine serum, GFP, green fluorescent protein, HMVEC, human microvascular endothelial cell, MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, α-SMA, α–smooth muscle actin, TGF, transforming growth factor, 3D, 3-dimensional, VEGF, vascular endothelial growth factor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by National Cancer Institute grant P01-CA098101 (to M.H.).The authors declare no financial conflicts of interest.

PII: S0016-5085(08)00299-0

doi:10.1053/j.gastro.2008.02.061

Gastroenterology
Volume 134, Issue 7 , Pages 1981-1993, June 2008